Home > PJ (current issue) > Products | Search
|
This article |
Products |
Accessing SPCs |
|
SPC changes
Calcium gluconate Humatrope A warning about use of Humatrope for patients with Prader-Willi syndrome has also been added. Seretide Seretide Accuhaler’s summary of product characteristics now states that use is indicated for the symptomatic treatment of patients with COPD with an FEV1 <60 per cent predicted normal (pre-bronchodilator) and a history of repeated exacerbations, who have significant symptoms despite regular bronchodilator therapy. The recommended dose for adults with COPD remains one inhalation of the 50/500µg strength Accuhaler twice daily. |
Supply issues Medrone Salinum Trinordiol |